← Eichor
Condition: Persistent Vulvar Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Persistent Vulvar Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Phase 2 · 2 location(s) · Dana-Farber Cancer Institute · NCT06677190Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer
Phase 2 · 15 location(s) · AGO Research GmbH · NCT05903833
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.